FR16C0033I1 - - Google Patents

Info

Publication number
FR16C0033I1
FR16C0033I1 FR16C0033C FR16C0033I1 FR 16C0033 I1 FR16C0033 I1 FR 16C0033I1 FR 16C0033 C FR16C0033 C FR 16C0033C FR 16C0033 I1 FR16C0033 I1 FR 16C0033I1
Authority
FR
France
Prior art keywords
hydroxypyrone
iron
reacting
carboxylic acid
aqueous solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of FR16C0033I1 publication Critical patent/FR16C0033I1/fr
Application granted granted Critical
Publication of FR16C0033I2 publication Critical patent/FR16C0033I2/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/40—Oxygen atoms attached in positions 3 and 4, e.g. maltol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compounds Of Iron (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR16C0033C 2002-05-18 2016-08-09 Methode de formation de composes d'hydroxypyrone de fer Active FR16C0033I2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0211500.4A GB0211500D0 (en) 2002-05-18 2002-05-18 Method of forming iron hydroxypyrone compounds
PCT/GB2003/001956 WO2003097627A1 (en) 2002-05-18 2003-05-07 Method of forming iron hydroxypyrone compounds

Publications (2)

Publication Number Publication Date
FR16C0033I1 true FR16C0033I1 (cs) 2016-09-23
FR16C0033I2 FR16C0033I2 (fr) 2018-01-19

Family

ID=9936987

Family Applications (1)

Application Number Title Priority Date Filing Date
FR16C0033C Active FR16C0033I2 (fr) 2002-05-18 2016-08-09 Methode de formation de composes d'hydroxypyrone de fer

Country Status (11)

Country Link
US (1) US7459569B2 (cs)
EP (1) EP1506183B1 (cs)
AT (1) ATE352547T1 (cs)
AU (1) AU2003233881A1 (cs)
BE (1) BE2016C041I2 (cs)
CA (1) CA2483067C (cs)
DE (1) DE60311456T2 (cs)
ES (1) ES2283771T3 (cs)
FR (1) FR16C0033I2 (cs)
GB (1) GB0211500D0 (cs)
WO (1) WO2003097627A1 (cs)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8952061B2 (en) * 2006-08-22 2015-02-10 University Of Virginia Patent Foundation Methods and compounds regulating the erythroid response to iron deficiency
EP2125847B1 (en) 2007-02-06 2015-06-17 Medical Research Council Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation
GB0808835D0 (en) 2008-05-15 2008-06-18 Vitra Pharmaceuticals Ltd Therapeutic compositions
US8536106B2 (en) 2010-04-14 2013-09-17 Ecolab Usa Inc. Ferric hydroxycarboxylate as a builder
GB201101370D0 (en) 2011-01-27 2011-03-09 Iron Therapeutics Holdings Ag Process
GB201404390D0 (en) * 2014-03-12 2014-04-23 Iron Therapeutics Holdings Ag Composition
US10172882B2 (en) 2014-06-22 2019-01-08 Dexcel Pharma Technologies Ltd. Pharmaceutical compositions comprising ferric citrate and methods for the production thereof
GB2531742B (en) * 2014-10-28 2016-10-05 Iron Therapeutics Holdings Ag Polymorphs of ferric maltol
GB201517893D0 (en) 2015-10-09 2015-11-25 Medical Res Council Methods for producing carboxylate ligand modified ferric iron hydroxide colloids
WO2017167963A1 (en) * 2016-03-31 2017-10-05 Medical Research Council Methods for producing ferric maltol compositions from ligand modified and ligand coated ferric hydroxides
EP3436442B1 (en) * 2016-03-31 2020-10-28 Shield TX (UK) Limited Methods for producing ferric maltol compositions from ferrous hydroxides
CN109071481B (zh) * 2016-03-31 2022-09-30 英国神盾Tx股份有限公司 用于由元素铁产生麦芽酚铁组合物的方法
EA201892194A1 (ru) 2016-03-31 2019-04-30 Юнайтед Киндом Рисёрч Энд Инновейшн Композиции комплекса трехвалентного железа с мальтолом для применения для лечения или предотвращения рака и опухолей
GB202005054D0 (en) 2020-04-06 2020-05-20 Nemysis Ltd Carboxylate Ligand Modified Ferric Iron Hydroxide Compositions for Use in the Treatment or Prevention of Iron Deficiency Associated with Liver Diseases
CN112574158B (zh) * 2020-12-29 2022-08-02 南京百泽医药科技有限公司 一种麦芽酚铁晶型ii及其制备方法
CN115177625A (zh) * 2022-06-28 2022-10-14 金陵药业股份有限公司 一种羧基麦芽糖铁药用组合物及其制备方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3130204A (en) * 1962-02-07 1964-04-21 Pfizer & Co C Preparation of gamma-pyrones
DE1518098A1 (de) * 1963-09-19 1969-04-10 Pfizer & Co C Verfahren zur Herstellung von Pyromekonsaeurederivaten
SE322866B (cs) * 1966-12-15 1970-04-20 Astra Ab
US4018907A (en) * 1975-08-25 1977-04-19 General Foods Corporation Coloring food with iron-complexes
US4212685A (en) * 1978-12-11 1980-07-15 Lea Manufacturing Company Protective and color receptive coating for aluminum
US4279936A (en) * 1979-09-24 1981-07-21 William Underwood Company Maltol treated canned meat process
DK157856C (da) * 1982-03-24 1990-07-30 Nat Res Dev Analogifremgangsmaade til fremstilling af et 3:1 hydroxypyridon:jern (iii)-kompleks
GR78491B (cs) 1982-03-24 1984-09-27 Nat Res Dev
EP0107458B1 (en) * 1982-10-22 1987-07-29 National Research Development Corporation Pharmaceutical compositions
GB8308055D0 (en) 1983-03-24 1983-05-05 Hider R C Pharmaceutical compositions
GB8308054D0 (en) * 1983-03-24 1983-05-05 Hider R C Pharmaceutical compositions
GB8325494D0 (en) 1983-09-23 1983-10-26 Hider R C Pharmaceutical compositions
US4912118A (en) 1983-09-23 1990-03-27 National Research Development Corporation Pharmaceutical compositions
USRE34313E (en) 1983-09-23 1993-07-13 National Research Development Corporation Pharmaceutical compositions
GB8325496D0 (en) * 1983-09-23 1983-10-26 Hider R C Pharmaceutical compositions
GB8329043D0 (en) * 1983-10-31 1983-11-30 Hider R C Pharmaceutical compositions
GB8410290D0 (en) * 1984-04-19 1984-05-31 Callingham B A Pharmaceutical compositions
US5177068A (en) 1984-04-19 1993-01-05 National Research Development Corporation Pharmaceutical compositions
GB8410289D0 (en) 1984-04-19 1984-05-31 Callingham B A Pharmaceutical compositions
GB8606913D0 (en) 1986-03-20 1986-04-23 Hider R C Treatment of sickle cell disease
JPH0367565A (ja) 1989-08-07 1991-03-22 Kansai Paint Co Ltd 鉄分強化食品
GB9209078D0 (en) 1992-04-27 1992-06-10 Hider Robert C Pharmaceutical compositions
GB9217099D0 (en) 1992-08-12 1992-09-23 British Tech Group Pharmaceutical compositions
WO1996041627A2 (en) 1995-06-10 1996-12-27 Vitra Pharmaceuticals Ltd Iron compounds, compositions, methods of making the same and uses thereof
GB9621273D0 (en) 1996-10-11 1996-11-27 Cortecs Ltd Therapeutic method

Also Published As

Publication number Publication date
EP1506183B1 (en) 2007-01-24
GB0211500D0 (en) 2002-06-26
BE2016C041I2 (cs) 2022-08-09
US20050250754A1 (en) 2005-11-10
EP1506183A1 (en) 2005-02-16
ES2283771T3 (es) 2007-11-01
CA2483067A1 (en) 2003-11-27
US7459569B2 (en) 2008-12-02
DE60311456T2 (de) 2007-11-15
FR16C0033I2 (fr) 2018-01-19
ATE352547T1 (de) 2007-02-15
DE60311456D1 (de) 2007-03-15
WO2003097627A1 (en) 2003-11-27
AU2003233881A1 (en) 2003-12-02
CA2483067C (en) 2011-04-26

Similar Documents

Publication Publication Date Title
BE2016C041I2 (cs)
EP2272825A3 (en) N-Protected amino hydroxy adamantane carboxylic acid and process for its preparation
MXPA03009565A (es) Derivado de acido carboxilico y una sal del mismo.
AU2001281028A1 (en) Dilute acid/metal salt hydrolysis of lignocellulosics
ZA200308319B (en) Method for producing an aqueous acrylamide solution with a biocatalyst.
MXPA01002392A (es) Metodos y composiciones acidificadas para reducir la corrosion en las superficies de metal y la precipitacion del sulfuro.
DK1438321T3 (da) Modificeret L-nukleinsyre
AU3309995A (en) Water soluble cyclic amine-dicarboxylic acid-alkanol amine salt corrosion inhibitor
WO2003088956A8 (en) Method for treating ileus with an alpha -ketoalkanoic acid or - ester or - amide
WO2003062344A3 (en) Acidizing and scale treatment of subterranean formation
PT1543826E (pt) Solução aquosa concentrada de ambroxol
TR199902759T2 (xx) Sertindole �retimi i�in bir y�ntem
PL365213A1 (en) Enteric ketoacid salts and amino acids
PL364087A1 (en) Method for the production of d-pantothenic acid and/or salts thereof as adjunct for animal feedstuffs
WO2004095921A3 (en) Sporicidal composition
IN2003CH01298A (en) Method for producing D-pantothenic acid and/or salt thereof as additive for animal feesdstuffs
IL157496A0 (en) Method for producing d-pantothenic acid and/or salts thereof as additive to animal feed
IN2003CH01297A (en) Method for producing D-pantothenic acid and/or salts thereof as an additive for animal feed
AU2002250978A1 (en) Method for producing D-pantothenic acid and/or salts thereof as an additive for animal feed
AU2001249606A1 (en) Method of cyanide salt production
RU2000109795A (ru) Способ получения магнитоактивного соединения
ZA947052B (en) Intravenously administrable aqueous solution
EP1245535A3 (en) An aqueous solution containing hydroxylamine salt and storing method thereof
TW287209B (en) Water soluble cyclic amine-dicarboxylic acid-alkanol amine salt corrosion inhibitor
EP1405843A4 (en) PROCESS FOR THE PREPARATION OF AMINO STILENE DERIVATIVES